BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 11280537)

  • 1. Early detection of pancreatic cancer in patients with chronic pancreatitis: diagnostic utility of a K-ras point mutation in the pancreatic juice.
    Queneau PE; Adessi GL; Thibault P; Cléau D; Heyd B; Mantion G; Carayon P
    Am J Gastroenterol; 2001 Mar; 96(3):700-4. PubMed ID: 11280537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of pancreatic cancer by K-ras point mutation and cytology of pancreatic juice.
    Uehara H; Nakaizumi A; Baba M; Iishi H; Tatsuta M; Kitamura T; Ohigashi H; Ishikawa O; Takenaka A; Ishiguro S
    Am J Gastroenterol; 1996 Aug; 91(8):1616-21. PubMed ID: 8759672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of pancreatic cancer by detecting telomerase activity in pancreatic juice: comparison with K-ras mutations.
    Uehara H; Nakaizumi A; Tatsuta M; Baba M; Takenaka A; Uedo N; Sakai N; Yano H; Iishi H; Ohigashi H; Ishikawa O; Okada S; Kakizoe T
    Am J Gastroenterol; 1999 Sep; 94(9):2513-8. PubMed ID: 10484017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of K-ras codon 12 point mutation in pancreatic juice in the diagnosis of carcinoma of the pancreas.
    Kimura W; Zhao B; Futakawa N; Muto T; Makuuchi M
    Hepatogastroenterology; 1999; 46(25):532-9. PubMed ID: 10228857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of point mutations in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma.
    Kondo H; Sugano K; Fukayama N; Kyogoku A; Nose H; Shimada K; Ohkura H; Ohtsu A; Yoshida S; Shimosato Y
    Cancer; 1994 Mar; 73(6):1589-94. PubMed ID: 8156485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of c-Ki-ras gene codon 12 mutations from pancreatic duct brushings in the diagnosis of pancreatic tumours.
    Van Laethem JL; Vertongen P; Deviere J; Van Rampelbergh J; Rickaert F; Cremer M; Robberecht P
    Gut; 1995 May; 36(5):781-7. PubMed ID: 7797131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: diagnostic utility and prognostic significance.
    Castells A; Puig P; Móra J; Boadas J; Boix L; Urgell E; Solé M; Capellà G; Lluís F; Fernández-Cruz L; Navarro S; Farré A
    J Clin Oncol; 1999 Feb; 17(2):578-84. PubMed ID: 10080602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitive and quantitative detection of KRAS2 gene mutations in pancreatic duct juice differentiates patients with pancreatic cancer from chronic pancreatitis, potential for early detection.
    Shi C; Fukushima N; Abe T; Bian Y; Hua L; Wendelburg BJ; Yeo CJ; Hruban RH; Goggins MG; Eshleman JR
    Cancer Biol Ther; 2008 Mar; 7(3):353-360. PubMed ID: 18075308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of pancreatic adenocarcinoma by detection of human telomerase reverse transcriptase messenger RNA in pancreatic juice with sample qualification.
    Seki K; Suda T; Aoyagi Y; Sugawara S; Natsui M; Motoyama H; Shirai Y; Sekine T; Kawai H; Mita Y; Waguri N; Kuroiwa T; Igarashi M; Asakura H
    Clin Cancer Res; 2001 Jul; 7(7):1976-81. PubMed ID: 11448913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of K-ras point mutation at codon 12 in pure pancreatic juice collected 3 years and 6 months before the clinical diagnosis of pancreatic cancer.
    Wakabayashi T; Sawabu N; Watanabe H; Morimoto H; Sugioka G; Takita Y
    Am J Gastroenterol; 1996 Sep; 91(9):1848-51. PubMed ID: 8792713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical usefulness of K-ras gene mutation detection and cytology in pancreatic juice in the diagnosis and screening of pancreatic cancer.
    Boadas J; Mora J; Urgell E; Puig P; Roca M; Cussó X; Capellà G; Lluís F; Farré A
    Eur J Gastroenterol Hepatol; 2001 Oct; 13(10):1153-9. PubMed ID: 11711770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 and K-ras mutations in pancreatic juice samples from patients with chronic pancreatitis.
    Löhr M; Müller P; Mora J; Brinkmann B; Ostwald C; Farré A; Lluis F; Adam U; Stubbe J; Plath F; Nizze H; Hopt UT; Barten M; Capellá G; Liebe S
    Gastrointest Endosc; 2001 Jun; 53(7):734-43. PubMed ID: 11375580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of p16 and K-ras mutation in pancreatic adenocarcinoma and chronic pancreatitis differential diagnosis.
    Talar-Wojnarowska R; Gasiorowska A; Smolarz B; Romanowicz-Makowska H; Strzelczyk J; Janiak A; Kulig A; Malecka-Panas E
    J Physiol Pharmacol; 2004 Jul; 55 Suppl 2():129-38. PubMed ID: 15608367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of K-ras mutations in pancreatic juice in the early diagnosis of pancreatic cancer.
    Berthélemy P; Bouisson M; Escourrou J; Vaysse N; Rumeau JL; Pradayrol L
    Ann Intern Med; 1995 Aug; 123(3):188-91. PubMed ID: 7598300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent deletions of tumor suppressor genes in pure pancreatic juice from patients with tumoral or nontumoral pancreatic diseases.
    Costentin L; Pagès P; Bouisson M; Berthelémy P; Buscail L; Escourrou J; Pradayrol L; Vaysse N
    Pancreatology; 2002; 2(1):17-25. PubMed ID: 12120000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors for pancreatic cancer in patients with chronic pancreatitis in association with K-ras gene mutation.
    Arvanitakis M; Van Laethem JL; Parma J; De Maertelaer V; Delhaye M; Devière J
    Endoscopy; 2004 Jun; 36(6):535-42. PubMed ID: 15202051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of K-ras and c-erbB-2 mutations in pancreatic adenocarcinoma and chronic pancreatitis.
    Talar-Wojnarowska R; Gasiorowska A; Smolarz B; Romanowicz-Makowska H; Strzelczyk J; Janiak A; Kulig A; Malecka-Panas E
    Int J Gastrointest Cancer; 2005; 35(1):33-41. PubMed ID: 15722572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of K-ras gene mutations at codon 12 in the pancreatic juice of patients with intraductal papillary mucinous tumors of the pancreas.
    Kondo H; Sugano K; Fukayama N; Hosokawa K; Ohkura H; Ohtsu A; Mukai K; Yoshida S
    Cancer; 1997 Mar; 79(5):900-5. PubMed ID: 9041151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia.
    Caldas C; Hahn SA; Hruban RH; Redston MS; Yeo CJ; Kern SE
    Cancer Res; 1994 Jul; 54(13):3568-73. PubMed ID: 8012983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of small pancreatic cancer diagnosed by serial follow-up studies promptly by a positive K-ras point mutation in pure pancreatic juice.
    Ochi K; Hasuoka H; Mizushima T; Matsumura N; Harada H
    Am J Gastroenterol; 1998 Aug; 93(8):1366-8. PubMed ID: 9707068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.